Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers D > Headlines for DUSA Pharmaceuticals, Inc. > News item |
DUSA files $75 million shelf registration
By Devika Patel
Knoxville, Tenn., May 16 - DUSA Pharmaceuticals, Inc. filed a $75 million shelf registration in an S-3 filing with the Securities and Exchange Commission.
The registration covers common stock, preferred stock, debt securities, depository shares and warrants. The preferreds and debt securities may be convertible.
Proceeds will be used for general corporate purposes.
Wilmington, Mass.-based DUSA is a dermatology company developing and marketing Levulan photodynamic therapy and other products targeting patients with common skin conditions.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.